Deferred Tax Assets, Net of Valuation Allowance of Nascent Biotech Inc. from 31 Mar 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Nascent Biotech Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Mar 2019 to 31 Mar 2024.
  • Nascent Biotech Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Mar 2024 was $0.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Nascent Biotech Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $0 $0 31 Mar 2024 10-K 01 Jul 2024 2024 FY
Q1 2023 $0 $0 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q1 2022 $0 $0 31 Mar 2022 10-K/A 03 Jul 2023 2023 FY
Q1 2021 $0 $0 31 Mar 2021 10-K 15 Jun 2022 2022 FY
Q1 2020 $0 $0 31 Mar 2020 10-K 08 Jul 2021 2021 FY
Q1 2019 $0 31 Mar 2019 10-K 22 Jun 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.